Chagas Disease Drug Discovery: Toward a New Era
Article Properties
-
LanguageEnglish
-
DOI (url)
-
Publication Date2015/01/01
-
Journal
-
Indian UGC (journal)
-
Refrences111
-
Citations194
-
Eric Chatelain
Cite
Chatelain, Eric. “Chagas Disease Drug Discovery: Toward a New Era”. SLAS Discovery, vol. 20, no. 1, 2015, pp. 22-35, https://doi.org/10.1177/1087057114550585.
Chatelain, E. (2015). Chagas Disease Drug Discovery: Toward a New Era. SLAS Discovery, 20(1), 22-35. https://doi.org/10.1177/1087057114550585
Chatelain E. Chagas Disease Drug Discovery: Toward a New Era. SLAS Discovery. 2015;20(1):22-35.
Journal Categories
Medicine
Medicine (General)
Science
Biology (General)
Science
Chemistry
Analytical chemistry
Science
Chemistry
Organic chemistry
Biochemistry
Technology
Chemical technology
Biotechnology
Refrences
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
| Randomized Trial of Posaconazole and Benznidazole for Chronic Chagas’ Disease | New England Journal of Medicine |
| 2014 | |
| New, Combined, and Reduced Dosing Treatment Protocols Cure Trypanosoma cruzi Infection in Mice | The Journal of Infectious Diseases |
| 105 | 2014 |
| Selection of Molecular Targets for Drug Development against Trypanosomatids | 2014 | |||
| The Expected Outcome of the Trypanosoma cruzi Proteomic Map: Review of Its Potential Biological Applications for Drug Target Discovery | 2014 | |||
| Antitrypanosomal Activity of Fexinidazole Metabolites, Potential New Drug Candidates for Chagas Disease | Antimicrobial Agents and Chemotherapy |
| 2014 |
Refrences Analysis
The category
Medicine: Internal medicine: Infectious and parasitic diseases 83
is the most frequently represented among the references in this article. It primarily includes studies from PLOS Neglected Tropical Diseases The chart below illustrates the number of referenced publications per year.
Refrences used by this article by year
Citations
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
Lignans Isolated from Piper truncatum Act as New Potent Antitrypanosomal Compounds | Chemistry & Biodiversity |
| 2024 | |
| At the outer part of the active site in Trypanosoma cruzi glucokinase: The role of phenylalanine 337 | Biochimie |
| 1 | 2024 |
Evaluation and discovery of novel benzothiazole derivatives as promising hits against Leishmania infantum | Chemical Biology & Drug Design |
| 2024 | |
Discovery of Strong 3-Nitro-2-Phenyl-2H-Chromene Analogues as Antitrypanosomal Agents and Inhibitors of Trypanosoma cruzi Glucokinase | International Journal of Molecular Sciences |
| 2024 | |
Chagas Disease: Comparison of Therapy with Nifurtimox and Benznidazole in Indigenous Communities in Colombia | Journal of Clinical Medicine |
| 2024 |
Citations Analysis
The category
Medicine: Therapeutics. Pharmacology 93
is the most commonly referenced area in studies that cite this article. The first research to cite this article was titled Preventing the transmission of American trypanosomiasis and its spread into non-endemic countries and was published in 2015. The most recent citation comes from a 2024 study titled Chagas Disease: Comparison of Therapy with Nifurtimox and Benznidazole in Indigenous Communities in Colombia. This article reached its peak citation in 2020, with 28 citations. It has been cited in 110 different journals, 24% of which are open access. Among related journals, the PLOS Neglected Tropical Diseases cited this research the most, with 14 citations. The chart below illustrates the annual citation trends for this article.